Entero Therapeutics, Inc. (ENTO)
USD 0.56
(-0.74%)
USD 0.56
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 29.27 Thousand | 106.2 Thousand | 537.4 Thousand | 571.14 Thousand | 976.98 Thousand | 798.44 Thousand |
| Gross Profit | -29.27 Thousand | -106.2 Thousand | -537.4 Thousand | -571.14 Thousand | -976.98 Thousand | -798.44 Thousand |
| Operating Expenses | 15.74 Million | 12.67 Million | 56.7 Million | 26.43 Million | 14.74 Thousand | 13.43 Thousand |
| Selling, General and Administrative Expenses | 10.73 Million | 11.98 Million | 18.38 Million | 7.29 Million | 6063.08 | 7450.37 |
| Research and Development Expenses | 5.03 Million | 691.25 Thousand | 38.32 Million | 19.13 Million | 8680.67 | 5771.41 |
| Other Expenses | - | -232.74 Thousand | 529.1 Thousand | 211.43 Thousand | - | - |
| Cost and Expenses | 15.77 Million | 12.67 Million | 56.7 Million | 26.43 Million | 14.74 Thousand | 13.43 Thousand |
| Operating Income | -15.77 Million | -12.67 Million | -59.05 Million | -26.43 Million | -14.74 Thousand | -13.22 Thousand |
| Interest Expense | 22.46 Thousand | 15.87 Thousand | 11.23 Thousand | 5.84 Million | - | - |
| Income Tax Expense | - | 126.56 Thousand | 26.52 Million | 15.11 Million | - | - |
| Earnings before Tax | -15.79 Million | -14.62 Million | -58.53 Million | -32.67 Million | -15.17 Thousand | -13.53 Thousand |
| Net Income | -15.79 Million | -14.62 Million | -58.53 Million | -32.67 Million | -15.17 Million | -13.53 Million |
| Earnings Per Share Basic | -47.88 | -416.93 | -39.77 Thousand | -61.63 Thousand | -28.42 Thousand | -36.81 Thousand |
| Earnings Per Share Diluted | -47.88 | -416.93 | -39.77 Thousand | -61.63 Thousand | -28.42 Thousand | -36.81 Thousand |
| Weighted Average Shares Outstanding | 336.34 Thousand | 35.91 Thousand | 2125.17 | 677.05 | 533.94 | 367.60 |
| Weighted Average Shares Outstanding (Diluted) | 336.34 Thousand | 35.91 Thousand | 2125.17 | 677.05 | 533.94 | 367.60 |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -15.74 Million | -14.5 Million | -57.98 Million | -26.25 Million | -13.76 Million | -12.63 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 35.59 Thousand | 12.29 Thousand | 7319.00 | 29.27 Thousand | 23.41 Thousand | 23.12 Thousand |
| Gross Profit | -35.59 Thousand | -12.29 Thousand | -7319.00 | -29.27 Thousand | -23.41 Thousand | -23.12 Thousand |
| Operating Expenses | 3.39 Million | 9.22 Million | 4.09 Million | 15.77 Million | 3.43 Million | 4.18 Million |
| Selling, General and Administrative Expenses | 3.17 Million | 8.65 Million | 2.78 Million | - | 2.42 Million | 2.82 Million |
| Research and Development Expenses | 219.59 Thousand | 565.96 Thousand | 1.3 Million | - | 1.01 Million | 1.35 Million |
| Other Expenses | - | -653.00 | -495.00 | -4224.00 | - | -2615.00 |
| Cost and Expenses | 3.42 Million | 9.22 Million | 4.09 Million | 15.77 Million | 3.43 Million | 4.18 Million |
| Operating Income | -3.42 Million | -9.22 Million | -4.09 Million | -15.77 Million | -3.43 Million | -4.18 Million |
| Interest Expense | - | 66.2 Thousand | 7048.00 | 22.46 Thousand | 1250.00 | 5178.00 |
| Income Tax Expense | 4.25 Million | -14.85 Million | 83.63 Thousand | 326.36 Thousand | 50.54 Thousand | 96.88 Thousand |
| Earnings before Tax | -3.43 Million | -9.29 Million | -4.1 Million | -15.79 Million | -3.43 Million | -4.18 Million |
| Net Income | -8.8 Million | 5.56 Million | -4.1 Million | -16.1 Million | -3.43 Million | -4.18 Million |
| Earnings Per Share Basic | -3.84 | 3.12 | -2.68 | - | -9.21 | -37.73 |
| Earnings Per Share Diluted | -3.84 | 0.38 | -2.68 | - | -9.21 | -37.73 |
| Weighted Average Shares Outstanding | 2.29 Million | 1.76 Million | 1.56 Million | 336.34 Thousand | 378.3 Thousand | 113.54 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 2.29 Million | 1.76 Million | 1.56 Million | 336.34 Thousand | 378.3 Thousand | 113.54 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.39 Million | -9.21 Million | -4.08 Million | - | -3.42 Million | -4.17 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
AVEFF
UV-R
1979
FFWM
4533
2322